Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group
作者
Cornelis J. A. Punt,Stefan Suciu,Madhuri Gore,Josef Koller,Wim H.J. Kruit,Janine Thomas,Poulam M. Patel,D Liénard,A.M.M. Eggermont,Ulrich Keilholz